Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cardiovascular
Neuroprotection
Drug Discovery
Inflammation/Pain
Autoimmune
Technical Glossary
Investors
Investor Welcome
ASX Announcements
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2023
2022
2021
2020
21-Dec-2020
57% Cholesterol Reduction from NYX-PCSK9i In Vivo Study
14-Dec-2020
Appointment of New Auditor
8-Dec-2020
Change in substantial holding
2-Dec-2020
Cleansing Statement
2-Dec-2020
Appendix 2A
26-Nov-2020
Change of Director's Interest Notice - JM
25-Nov-2020
Change of Director's Interest Notice - MF
25-Nov-2020
Appendix 2A
19-Nov-2020
Nyrada Annual General Meeting Results
19-Nov-2020
Presentation to 2020 Annual General Meeting of Shareholders
1
2
3
4
5
6
7
8
Next
